Combined blockade of <scp>GPX4</scp> and activated <scp>EGFR</scp>/<scp>HER3</scp> bypass pathways inhibits the development of <scp>ALK</scp>‐inhibitor‐induced tolerant persister cells in <scp><i>ALK</i></scp>‐fusion‐positive lung cancerKoh Furugaki, Shigeki Yoshiura|Molecular Oncology|2024Cited by 7
Targeting ErbB and tankyrase1/2 prevent the emergence of drug-tolerant persister cells in ALK-positive lung cancerTakaaki Fujimura, Shigeki Yoshiura|npj Precision Oncology|2024Cited by 7
Targeting ErbB and tankyrase1/2 prevent the emergence of drug tolerant persister cells in ALK fusion positive lung cancerShigeki Yoshiura, Ryohei Katayama|Research Square|2023Cited by 0